Physiologic mechanisms opposing the hemodynamic effects of prazosin View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1981-01

AUTHORS

Joseph L Izzo, David Horwitz, Harry R Keiser

ABSTRACT

Prazosin was give for 10 to 14 days to eight hypertensive patients on a fixed intake of dietary salt. Except as limited by side effects, the dose was increased from 2 mg/day to a maximum dose of 24 mg/day. During treatment, when subjects were studied in supine and upright positions, mean arterial pressure (MAP) fell 6% and 12% (p less than 0.025 and p less than 0.005), heart rate rose 3% and 9% (p less than 0.05 and p less than 0.005), and plasma norepinephrine increased 95% and 107% (p less than 0.01 and p less than 0.001) over control. Daily excretion of the norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) increased 42% and 17% (p less than 0.05 for each) during treatment. There were no changes in average body weight or plasma renin for the group, but patients whose body weight increased tended to show less reduction in blood pressure (correlation coefficient, r = 0.72, p less than 0.05) and smaller increases in heart rate (r = -.073, p less than 0.05) during treatment with prazosin. These data suggest that expansion of extracellular fluid and activation of the sympathetic nervous system oppose the hemodynamic effects of prazosin. More... »

PAGES

7-11

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/clpt.1981.2

DOI

http://dx.doi.org/10.1038/clpt.1981.2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038348725

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/7460477


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1116", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Physiology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Pressure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Extracellular Space", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemodynamics", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypertension", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Norepinephrine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Posture", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prazosin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quinazolines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sympathetic Nervous System", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Department of Medicine University of Rochester Rochester", 
            "Hypertension\u2010Endocrine Branch, National Heart Lung", 
            "Blood Institute, National Institutes of Health Bethesda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Izzo", 
        "givenName": "Joseph L", 
        "id": "sg:person.01174457147.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174457147.49"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Department of Medicine University of Rochester Rochester", 
            "Hypertension\u2010Endocrine Branch, National Heart Lung", 
            "Blood Institute, National Institutes of Health Bethesda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Horwitz", 
        "givenName": "David", 
        "id": "sg:person.01166013535.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166013535.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Rochester", 
          "id": "https://www.grid.ac/institutes/grid.16416.34", 
          "name": [
            "Department of Medicine University of Rochester Rochester", 
            "Hypertension\u2010Endocrine Branch, National Heart Lung", 
            "Blood Institute, National Institutes of Health Bethesda"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Keiser", 
        "givenName": "Harry R", 
        "id": "sg:person.0663532737.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663532737.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0009-8981(62)90022-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001808232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0009-8981(62)90022-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001808232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.55.3.533", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006609737"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(79)90185-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023925806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(77)91822-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029304003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(79)90409-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035662457"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0002-9149(78)90735-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043586068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1552-4604.1979.tb02508.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050182884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jcem-29-10-1349", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064306791"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1981-01", 
    "datePublishedReg": "1981-01-01", 
    "description": "Prazosin was give for 10 to 14 days to eight hypertensive patients on a fixed intake of dietary salt. Except as limited by side effects, the dose was increased from 2 mg/day to a maximum dose of 24 mg/day. During treatment, when subjects were studied in supine and upright positions, mean arterial pressure (MAP) fell 6% and 12% (p less than 0.025 and p less than 0.005), heart rate rose 3% and 9% (p less than 0.05 and p less than 0.005), and plasma norepinephrine increased 95% and 107% (p less than 0.01 and p less than 0.001) over control. Daily excretion of the norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) increased 42% and 17% (p less than 0.05 for each) during treatment. There were no changes in average body weight or plasma renin for the group, but patients whose body weight increased tended to show less reduction in blood pressure (correlation coefficient, r = 0.72, p less than 0.05) and smaller increases in heart rate (r = -.073, p less than 0.05) during treatment with prazosin. These data suggest that expansion of extracellular fluid and activation of the sympathetic nervous system oppose the hemodynamic effects of prazosin.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/clpt.1981.2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2423965", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2670579", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "name": "Physiologic mechanisms opposing the hemodynamic effects of prazosin", 
    "pagination": "7-11", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b6adcf6e9921ed461bbef2adee6a7455104c43bb0cede5d5f3847e793f45a0f8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "7460477"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/clpt.1981.2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038348725"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/clpt.1981.2", 
      "https://app.dimensions.ai/details/publication/pub.1038348725"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T21:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8690_00000066.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.1981.2/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/clpt.1981.2'


 

This table displays all metadata directly associated to this object as RDF triples.

173 TRIPLES      21 PREDICATES      52 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/clpt.1981.2 schema:about N03a846ee31d64adfaef45199ddb064bb
2 N147256560c534b8fac6d64d18d76c6e2
3 N14cef5c483ea4a84ae872a31fe2f978b
4 N16f5bce8024f42f088c8dbe76cbbea20
5 N2b69d789f12747abaa6d1fafc69f0cca
6 N555c01bebaf845ab9146ec91ac677e1a
7 N9d55bd3238bd4693afe992555e20d44f
8 Na8ac890ce91c4810b851b3bd779a477f
9 Nc118c134c2b74b6fbd0d87d95ec8525a
10 Nc157bb057be04e128aadcbf88fbd8134
11 Ne08557caa8da45efa48965ab439aa204
12 Ne0c485a980264fb3b2abc7e7a3980078
13 Ne73b9ed5762f4f9098ac4314205a0f9a
14 Nedf7a532cd354026ba88f49d5b7fe4c3
15 Nf387b749a77e432b8f51bf521f50c347
16 anzsrc-for:11
17 anzsrc-for:1116
18 schema:author N6e256c43b65c4b70b3bae5720ff752a3
19 schema:citation https://doi.org/10.1002/j.1552-4604.1979.tb02508.x
20 https://doi.org/10.1016/0002-9149(78)90735-x
21 https://doi.org/10.1016/0002-9149(79)90185-1
22 https://doi.org/10.1016/0002-9149(79)90409-0
23 https://doi.org/10.1016/0009-8981(62)90022-0
24 https://doi.org/10.1016/s0140-6736(77)91822-0
25 https://doi.org/10.1161/01.cir.55.3.533
26 https://doi.org/10.1210/jcem-29-10-1349
27 schema:datePublished 1981-01
28 schema:datePublishedReg 1981-01-01
29 schema:description Prazosin was give for 10 to 14 days to eight hypertensive patients on a fixed intake of dietary salt. Except as limited by side effects, the dose was increased from 2 mg/day to a maximum dose of 24 mg/day. During treatment, when subjects were studied in supine and upright positions, mean arterial pressure (MAP) fell 6% and 12% (p less than 0.025 and p less than 0.005), heart rate rose 3% and 9% (p less than 0.05 and p less than 0.005), and plasma norepinephrine increased 95% and 107% (p less than 0.01 and p less than 0.001) over control. Daily excretion of the norepinephrine metabolites methoxyhydroxyphenyl glycol (MHPG) and vanillylmandelic acid (VMA) increased 42% and 17% (p less than 0.05 for each) during treatment. There were no changes in average body weight or plasma renin for the group, but patients whose body weight increased tended to show less reduction in blood pressure (correlation coefficient, r = 0.72, p less than 0.05) and smaller increases in heart rate (r = -.073, p less than 0.05) during treatment with prazosin. These data suggest that expansion of extracellular fluid and activation of the sympathetic nervous system oppose the hemodynamic effects of prazosin.
30 schema:genre research_article
31 schema:inLanguage en
32 schema:isAccessibleForFree false
33 schema:isPartOf N1758305d742341fcbde9a6e76a6c0d8b
34 Ndb2e3805f6644bbd90dca1d347be6278
35 sg:journal.1017409
36 schema:name Physiologic mechanisms opposing the hemodynamic effects of prazosin
37 schema:pagination 7-11
38 schema:productId N0253001d0074400cbaa4bcf50b736cc6
39 N460b2e63048a44ef9c51a209345f3e99
40 N7473e6ec557e4619a2fd818a012a702e
41 Nb6a1bdbd6c2f44db83bd45f0f5d60ef3
42 Nd933b7c0ecff4a36b35992a91919f239
43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038348725
44 https://doi.org/10.1038/clpt.1981.2
45 schema:sdDatePublished 2019-04-10T21:59
46 schema:sdLicense https://scigraph.springernature.com/explorer/license/
47 schema:sdPublisher N4c3a65ecfa0c4873afe2baed9378f44c
48 schema:url http://onlinelibrary.wiley.com/doi/10.1038/clpt.1981.2/abstract
49 sgo:license sg:explorer/license/
50 sgo:sdDataset articles
51 rdf:type schema:ScholarlyArticle
52 N0253001d0074400cbaa4bcf50b736cc6 schema:name pubmed_id
53 schema:value 7460477
54 rdf:type schema:PropertyValue
55 N03a846ee31d64adfaef45199ddb064bb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
56 schema:name Adult
57 rdf:type schema:DefinedTerm
58 N147256560c534b8fac6d64d18d76c6e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
59 schema:name Blood Pressure
60 rdf:type schema:DefinedTerm
61 N14cef5c483ea4a84ae872a31fe2f978b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
62 schema:name Heart Rate
63 rdf:type schema:DefinedTerm
64 N16f5bce8024f42f088c8dbe76cbbea20 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Hemodynamics
66 rdf:type schema:DefinedTerm
67 N1758305d742341fcbde9a6e76a6c0d8b schema:issueNumber 1
68 rdf:type schema:PublicationIssue
69 N2b69d789f12747abaa6d1fafc69f0cca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
70 schema:name Norepinephrine
71 rdf:type schema:DefinedTerm
72 N460b2e63048a44ef9c51a209345f3e99 schema:name doi
73 schema:value 10.1038/clpt.1981.2
74 rdf:type schema:PropertyValue
75 N4c3a65ecfa0c4873afe2baed9378f44c schema:name Springer Nature - SN SciGraph project
76 rdf:type schema:Organization
77 N555c01bebaf845ab9146ec91ac677e1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Posture
79 rdf:type schema:DefinedTerm
80 N6e256c43b65c4b70b3bae5720ff752a3 rdf:first sg:person.01174457147.49
81 rdf:rest Nea55bcb0c2bc49bba9de95d41de91f9d
82 N7473e6ec557e4619a2fd818a012a702e schema:name readcube_id
83 schema:value b6adcf6e9921ed461bbef2adee6a7455104c43bb0cede5d5f3847e793f45a0f8
84 rdf:type schema:PropertyValue
85 N7c8d925df0d7435f970df576b290987b rdf:first sg:person.0663532737.84
86 rdf:rest rdf:nil
87 N9d55bd3238bd4693afe992555e20d44f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Male
89 rdf:type schema:DefinedTerm
90 Na8ac890ce91c4810b851b3bd779a477f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Prazosin
92 rdf:type schema:DefinedTerm
93 Nb6a1bdbd6c2f44db83bd45f0f5d60ef3 schema:name dimensions_id
94 schema:value pub.1038348725
95 rdf:type schema:PropertyValue
96 Nc118c134c2b74b6fbd0d87d95ec8525a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Female
98 rdf:type schema:DefinedTerm
99 Nc157bb057be04e128aadcbf88fbd8134 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Sympathetic Nervous System
101 rdf:type schema:DefinedTerm
102 Nd933b7c0ecff4a36b35992a91919f239 schema:name nlm_unique_id
103 schema:value 0372741
104 rdf:type schema:PropertyValue
105 Ndb2e3805f6644bbd90dca1d347be6278 schema:volumeNumber 29
106 rdf:type schema:PublicationVolume
107 Ne08557caa8da45efa48965ab439aa204 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Quinazolines
109 rdf:type schema:DefinedTerm
110 Ne0c485a980264fb3b2abc7e7a3980078 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Middle Aged
112 rdf:type schema:DefinedTerm
113 Ne73b9ed5762f4f9098ac4314205a0f9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Hypertension
115 rdf:type schema:DefinedTerm
116 Nea55bcb0c2bc49bba9de95d41de91f9d rdf:first sg:person.01166013535.73
117 rdf:rest N7c8d925df0d7435f970df576b290987b
118 Nedf7a532cd354026ba88f49d5b7fe4c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Humans
120 rdf:type schema:DefinedTerm
121 Nf387b749a77e432b8f51bf521f50c347 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Extracellular Space
123 rdf:type schema:DefinedTerm
124 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
125 schema:name Medical and Health Sciences
126 rdf:type schema:DefinedTerm
127 anzsrc-for:1116 schema:inDefinedTermSet anzsrc-for:
128 schema:name Medical Physiology
129 rdf:type schema:DefinedTerm
130 sg:grant.2423965 http://pending.schema.org/fundedItem sg:pub.10.1038/clpt.1981.2
131 rdf:type schema:MonetaryGrant
132 sg:grant.2670579 http://pending.schema.org/fundedItem sg:pub.10.1038/clpt.1981.2
133 rdf:type schema:MonetaryGrant
134 sg:journal.1017409 schema:issn 0009-9236
135 1532-6535
136 schema:name Clinical Pharmacology & Therapeutics
137 rdf:type schema:Periodical
138 sg:person.01166013535.73 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
139 schema:familyName Horwitz
140 schema:givenName David
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01166013535.73
142 rdf:type schema:Person
143 sg:person.01174457147.49 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
144 schema:familyName Izzo
145 schema:givenName Joseph L
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174457147.49
147 rdf:type schema:Person
148 sg:person.0663532737.84 schema:affiliation https://www.grid.ac/institutes/grid.16416.34
149 schema:familyName Keiser
150 schema:givenName Harry R
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0663532737.84
152 rdf:type schema:Person
153 https://doi.org/10.1002/j.1552-4604.1979.tb02508.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1050182884
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/0002-9149(78)90735-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043586068
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/0002-9149(79)90185-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023925806
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/0002-9149(79)90409-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035662457
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1016/0009-8981(62)90022-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001808232
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1016/s0140-6736(77)91822-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029304003
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1161/01.cir.55.3.533 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006609737
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1210/jcem-29-10-1349 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064306791
168 rdf:type schema:CreativeWork
169 https://www.grid.ac/institutes/grid.16416.34 schema:alternateName University of Rochester
170 schema:name Blood Institute, National Institutes of Health Bethesda
171 Department of Medicine University of Rochester Rochester
172 Hypertension‐Endocrine Branch, National Heart Lung
173 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...